ZimVie Inc. (ZIMV)

NASDAQ: ZIMV · IEX Real-Time Price · USD
23.12
0.10 (0.43%)
May 25, 2022 4:00 PM EDT - Market closed
Market Cap602.97M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out26.08M
EPS (ttm)-4.66
PE Ration/a
Forward PE11.03
Dividendn/a
Ex-Dividend Daten/a
Volume240,034
Open22.71
Previous Close23.02
Day's Range22.25 - 23.55
52-Week Range18.83 - 50.40
Betan/a
AnalystsSell
Price Targetn/a
Earnings DateMay 5, 2022

About ZIMV

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-sp...

IndustryMedical Devices
Founded2021
Employees2,700
Stock ExchangeNASDAQ
Ticker SymbolZIMV
Full Company Profile

Financial Performance

In 2021, ZimVie's revenue was $1.01 billion, an increase of 11.20% compared to the previous year's $912.40 million. Losses were -$95.30 million, -46.79% less than in 2020.

Financial Statements

News

ZimVie Reports First Quarter 2022 Financial Results

WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the quarter ended Mar...

2 weeks ago - GlobeNewsWire

ZimVie to Report First Quarter 2022 Financial Results on May 5, 2022

WESTMINSTER, Colo., April 12, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the first...

1 month ago - GlobeNewsWire

ZimVie Reports 2021 Financial Results, Reaffirms 2022 Financial Guidance, and Provides Supplemental Financial Informa...

WESTMINSTER, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the three months an...

1 month ago - GlobeNewsWire

ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors

WESTMINSTER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV) today announced its debut as an independent publicly traded company and the completion of its separation from Zimmer Bio...

2 months ago - GlobeNewsWire